Phase I trial of chimeric (human-mouse) monoclonal antibody L6 in patients with non-small-cell lung, colon, and breast cancer (original) (raw)

Access this article

Log in via an institution

Subscribe and save

• Starting from 10 chapters or articles per month
• Access and download chapters and articles from more than 300k books and 2,500 journals
• Cancel anytime View plans

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

1. Bajorin DF, Chapman PB, Wong G, Coi DG, Kunicka J, Dimaggio J, Cordon-Cardo C, Urmacher C, Dantes L, Templeton MA, Liu J, Oettgen HF, Houghton AN (1990) Phase I evaluation of a combination of monoclonal antibody R24 and interleukin 2 in patients with metastatic melanoma. Cancer Res 50: 7490–7495
   Google Scholar
2. DeNardo SJ, O'Grady LF, Macey DJ, Kroger LA, McNardo GL, Lamborn KR, Levy NB, Mills SL, Hellstrom I, Hellstrom KE (1991) Quantitative imaging of mouse L6 monoclonal antibody in breast cancer patients to develop a therapeutic strategy. Nucl Med Biol 18: 621–631
   Google Scholar
3. DeNardo SJ, Warhoe KA, O'Grady LF, Hellstrom I, Hellstrom KE, Mills SL, Macey DJ, Goodnight JE, DeNardo GL (1991) Radioimmunotherapy for breast cancer: treatment of a patient with I-131 LG chimetric monoclonal antibody. Int J Biol Markers 6: 221–230
   Google Scholar
4. Epenetos AA, Kosmas C (1989) Monoclonal antibodies for imaging and therapy. Br J Cancer 59: 152
   Google Scholar
5. Fell HP, Gayle MA, Schieven G, Yelton D, Lipsich L, Hellstrom I, Hellstrom KE, Bajorath J (1992) Chimeric L6 anti-tumor antibody: genomic construction, variable region gone sequencing, and binding site modeling. J Biol Chem (in press)
6. Garrigues HJ, Tilgen W, Hellstrom I, Franke W, Hellstrom KE (1982) Detection of a human melanoma-associated antigen, p97, in histological sections of primary human melanomas. Int J Cancer 29: 511–515
   Google Scholar
7. Goodman GE, Beaumier PL, Hellstrom I, Fernyhough B, Hellstrom KE (1985) Pilot trial of murine monoclonal antibodies in patients with advanced melanoma. J Clin Oncol 3: 340
   Google Scholar
8. Goodman GE, Hellstrom I, Brodzinsky L, Nicaise C, Kulander B, Hummel D, Hellstrom KE (1990) Phase I trial of murine monoclonal antibody L6 in breast, colon, ovarian, and lung cancer. J Clin Oncol 8: 1083–1092
   Google Scholar
9. Hank JA, Robinson RR, Sufus J, Mueller BM, Reisfeld RA, Cheung NK, Sondel PM (1990) Augmentation of antibody dependent cell mediated cytotoxicity following in vivo therapy with recombinant interleukin 2. Cancer Res 50: 5234–5239
   Google Scholar
10. Hellstrom KE, Hellstrom I (1991) Principles of tumor immunity: tumor antigens. In: DeVita VT, Hellman S, Rosenberg SA (eds) Biologic therapy of cancer: principles and practice. Lippincott, Philadelphia, pp 35–52
    Google Scholar
11. Hellstrom I, Beaumier PL, Hellstrom KE (1986) Antitumor effects of L6, an IgG2a antibody reacting with most human carcinomas. Proc Natl Acad Sci USA 83: 7059
    Google Scholar
12. Hellstrom I, Garrigues U, Lavie E, Hellstrom KE (1988) Antibodymediated killing of human tumor cells by attached effector cells. Cancer Res 48: 624–627
    Google Scholar
13. Koprowski H, Herlyn D, Lubeck M, DeFreitas E, Scars HF (1984) Human anti-idiotype antibodies in cancer patients: is the modulation of the immune response beneficial for the patient. Proc Natl Acad Sci USA 81: 216–219
    Google Scholar
14. Liu AY, Robinson RR, Hellstrom KE, Murray ED Jr, Chang CP, Hellstrom I (1987) Chimeric mouse-human IgG1 antibody that can mediate lysis of cancer cells. Proc Natl Acad Sci USA 84: 3439–3443
    Google Scholar
15. Marken JS, Schieven GL, Hellstrom I, Hellstrom KE, Aruffo A (1992) Cloning and expression of the tumor-associated antigen L6. Proc Natl Acad Sci USA 89: 3503–3507
    Google Scholar
16. Schultz KR, Klarnet JP, Peace DJ, Cheever MA, Badger CC, Bernstein ID, Greenberg PD (1990) Monoclonal antibody therapy of murine lymphoma: Enhanced efficacy by concurrent administration of interleukin 2 or lymphokine-activated killer cells. Cancer Res 50: 5421–5425
    Google Scholar
17. Shaw DR, Khazaeli MB, LoBuglio AF (1989) Biologic activity of mouse/human chimeric antibodies of the human IgG subclasses with specificity for a tumor associated antigen. Proc Natl Acad Sci USA 86: 4220–4224
    Google Scholar
18. Sternberger LA (1979) The unlabeled antibody peroxidase-antiperoxidase (PAP) method. In: Sternberger LA (ed) Immunocytochemistry. Wiley, New York, pp 104–169
    Google Scholar
19. Vadhan-Raj S, Cordon-Cardo C, Carswell E, Mintzer D, Dantis L, Duteau C, Templeton MA, Dettgen HF, Old LJ, Houghton AN (1988) Phase I trial of a mouse monoclonal antibody against GD3 ganglioside in patients with melanoma: induction of inflammatory responses at tumor sites. J Clin Oncol 6: 1636–1648
    Google Scholar

Download references